GenMark Diagnostics Inc (GNMK)


Stock Price Forecast

April 21, 2021


Forecasted Returns

7 Days Predict

30 Days Predict

90 Days Predict


Forecasted Market-Excess Returns

7 Days Predict

30 Days Predict

90 Days Predict

Loading GenMark Diagnostics Inc chart...

About the Company

We do not have any company description for GenMark Diagnostics Inc at the moment.

Exchange

NASDAQ/NMS (GLOBAL MARKET)

$172M

Total Revenue

437

Employees

$2B

Market Capitalization

-85.86

Price/Earning ratio

Fundamental Data and Insider Transactions (Quarterly data) Full Screen

Loading the fundamentals chart...

Latest $GNMK News

GenMark Diagnostics Submits Test for Coronavirus to FDA

4y ago, source: TheStreet.com

GenMark Diagnostics submitted a test for coronavirus to the Food and Drug Administration. The company seeks quick clearance of the test through an FDA emergency-use authorization. Shares of ...

Roche expands COVID testing portfolio with $1.8bn GenMark deal

3y ago, source: pharmaphorum

Meanwhile, GenMark said that the deal will help expand the reach of its products. “Together with Roche’s diagnostics healthcare solutions, we will be able to provide a full suite of molecular ...

Swiss pharma giant Roche to buy American firm GenMark Diagnostics for $1.8 billion

3y ago, source: health.economictimes.indiatimes

Swiss pharma giant Roche said Monday it is buying US firm GenMark Diagnostics for $1.8 billion (1.5 billion euros). GenMark, based in California, makes molecular tests which can establish the ...

Bluejay Diagnostics, Inc.

1y ago, source: CNN

Bluejay Diagnostics, Inc. operates as a diagnostic company. It develops and markets minimally-invasive Point-of-Care diagnostics tests and devices that provide patients and providers with access ...

Influenza Diagnostics Market Share Estimated to Reach USD 1.46 Billion By 2032, at 7.1% CAGR Growth: Polaris Market Research

20d ago, source: Yahoo Finance

New York, NY, March 08, 2024 (GLOBE NEWSWIRE) -- The latest research report [115+] pages with 360-degree visibility, titled “Influenza Diagnostics Market Share, Size, Trends, Industry Analysis ...

Accelerate Diagnostics Inc.

28d ago, source: Wall Street Journal

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Quest Diagnostics Inc DGX

6d ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

LUCD Lucid Diagnostics Inc.

6d ago, source: Seeking Alpha

Lucid Diagnostics Inc. operates as a commercial-stage medical diagnostics technology company. The company focuses on patients with gastroesophageal reflux disease who are at risk of developing ...

Accelerate Diagnostics Inc AXDX

9d ago, source: Morningstar

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings ...

Quest Diagnostics Inc.

3y ago, source: Wall Street Journal

No significant news for in the past two years. Key Stock Data P/E Ratio (TTM) The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing ...

LUCD Lucid Diagnostics Inc.

1mon ago, source: Seeking Alpha

Lucid Diagnostics Inc. operates as a commercial-stage medical diagnostics technology company. The company focuses on patients with gastroesophageal reflux disease who are at risk of developing ...

Latest Neutral (free) Forecasts

STRONG BUY BUY NEUTRAL SELL STRONG SELL ALL

Loading the latest forecasts...

My Portfolio

Loading your portfolio...